Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34551229

Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2021 Sep 23
First author
Nathan P

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2021 Dec;18(12):747. doi: 10.1038/s41571-021-00572-3.
    note
    Source null
    related pmid
    34625736
    relationship
    Comment in
  2. citation
    Cancer Cell. 2021 Nov 8;39(11):1461-1463. doi: 10.1016/j.ccell.2021.10.005.
    note
    Source null
    related pmid
    34752755
    relationship
    Comment in

Authors and identifiers

  1. name
    Nathan P
    type
    Author
  2. name
    Hassel JC
    type
    Author
  3. name
    Rutkowski P
    type
    Author
  4. name
    Baurain JF
    type
    Author
  5. name
    Butler MO
    type
    Author
  6. name
    Schlaak M
    type
    Author
  7. name
    Sullivan RJ
    type
    Author
  8. name
    Ochsenreither S
    type
    Author
  9. name
    Dummer R
    type
    Author
  10. name
    Kirkwood JM
    type
    Author
  11. name
    Joshua AM
    type
    Author
  12. name
    Sacco JJ
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Nathan P
    type
    Author
  2. name
    Hassel JC
    type
    Author
  3. name
    Rutkowski P
    type
    Author
  4. name
    Baurain JF
    type
    Author
  5. name
    Butler MO
    type
    Author
  6. name
    Schlaak M
    type
    Author
  7. name
    Sullivan RJ
    type
    Author
  8. name
    Ochsenreither S
    type
    Author
  9. name
    Dummer R
    type
    Author
  10. name
    Kirkwood JM
    type
    Author
  11. name
    Joshua AM
    type
    Author
  12. name
    Sacco JJ
    type
    Author
bibliography ids
  1. nci-bib-3dd69ee55d804aaa42fa3409
book metadata
content sha256
857d68c8582130594b3c8f3f8dd7d64d19258619dc7b99afb3ff4c0af47f84e0
document type
citation
dois
  1. 10.1056/NEJMoa2103485
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:34551229
immutable id
pubmed:34551229@857d68c8582130594b3c8f3f8dd7d64d19258619dc7b99afb3ff4c0af47f84e0
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
13
name
The New England journal of medicine
nlm unique id
0255562
pages
1196-1206
volume
385
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2021 Dec;18(12):747. doi: 10.1038/s41571-021-00572-3.
    note
    Source null
    related pmid
    34625736
    relationship
    Comment in
  2. citation
    Cancer Cell. 2021 Nov 8;39(11):1461-1463. doi: 10.1016/j.ccell.2021.10.005.
    note
    Source null
    related pmid
    34752755
    relationship
    Comment in
outcomes validated
false
pmid
34551229
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
59ec7076bb15e97a4ff520792720628830d1bed4eab1c8dc7e92d0dcb28c7f00
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Sep 23
precision
day
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34551229/
title
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma.

Preserved source evidence · Not medical advice